» Articles » PMID: 21490903

Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma

Overview
Journal AIDS Res Treat
Publisher Wiley
Date 2011 Apr 15
PMID 21490903
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background. The homeostatic chemokine, CXCL13 (BLC, BCA-1), helps direct the recirculation of mature, resting B cells, which express its receptor, CXCR5. CXCL13/CXCR5 are expressed, and may play a role, in some non-AIDS-associated B cell tumors. Objective. To determine if CXCL13/CXCR5 are associated with AIDS-related non-Hodgkin's lymphoma (AIDS-NHL). Methods. Serum CXCL13 levels were measured by ELISA in 46 subjects who developed AIDS-NHL in the Multicenter AIDS Cohort Study and in controls. The expression or function of CXCL13 and CXCR5 was examined on primary AIDS-NHL specimens or AIDS-NHL cell lines. Results. Serum CXCL13 levels were significantly elevated in the AIDS-NHL group compared to controls. All primary AIDS-NHL specimens showed CXCR5 expression and most also showed CXCL13 expression. AIDS-NHL cell lines expressed CXCR5 and showed chemotaxis towards CXCL13. Conclusions. CXCL13/CXCR5 are expressed in AIDS-NHL and could potentially be involved in its biology. CXCL13 may have potential as a biomarker for AIDS-NHL.

Citing Articles

Characterization of unique B-cell populations in the circulation of people living with HIV prior to non-Hodgkin lymphoma diagnosis.

Martinez L, Comin-Anduix B, Guemes-Aragon M, Ibarrondo J, Detels R, Mimiaga M Front Immunol. 2024; 15():1441994.

PMID: 39324141 PMC: 11422120. DOI: 10.3389/fimmu.2024.1441994.


Follicular CD8+ T Cells Are Elevated in HIV Infection and Induce PD-L1 on B Cells.

Martinez L, Ibarrondo J, Guo Y, Penichet M, Epeldegui M J Immunol. 2022; 210(1):33-39.

PMID: 36445393 PMC: 9840893. DOI: 10.4049/jimmunol.2200194.


Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes.

Levin L, Ramirez C, Liao E, Guo H, Kim B, Marrogi A Cancer Epidemiol Biomarkers Prev. 2022; 32(2):233-241.

PMID: 36409490 PMC: 9905313. DOI: 10.1158/1055-9965.EPI-22-0247.


Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.

Rhee J, Birmann B, De Roos A, Epstein M, Martinez-Maza O, Breen E Int J Cancer. 2022; 152(5):865-878.

PMID: 36151863 PMC: 9812887. DOI: 10.1002/ijc.34299.


CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities.

Gao S, Liu S, Wang G, Zhou G Life (Basel). 2021; 11(12).

PMID: 34947813 PMC: 8708574. DOI: 10.3390/life11121282.


References
1.
Burkle A, Niedermeier M, Schmitt-Graff A, Wierda W, Keating M, Burger J . Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood. 2007; 110(9):3316-25. DOI: 10.1182/blood-2007-05-089409. View

2.
Deutsch A, Aigelsreiter A, Steinbauer E, Fruhwirth M, Kerl H, Beham-Schmid C . Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol. 2008; 215(4):431-44. DOI: 10.1002/path.2372. View

3.
Walser T, Fulton A . The role of chemokines in the biology and therapy of breast cancer. Breast Dis. 2005; 20:137-43. DOI: 10.3233/bd-2004-20114. View

4.
Chan C, Shen D, Hackett J, Buggage R, Tuaillon N . Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology. 2003; 110(2):421-6. DOI: 10.1016/S0161-6420(02)01737-2. View

5.
Carbone A, Gloghini A, Capello D, Gaidano G . Genetic pathways and histogenetic models of AIDS-related lymphomas. Eur J Cancer. 2001; 37(10):1270-5. DOI: 10.1016/s0959-8049(01)00119-8. View